Traits of the metabolic syndrome alter corpulent obesity in LAN, SHR and DSS rats: Behavioral and metabolic interactions with adrenalectomy

Physiology and Behavior

Volumn 103, Issue 1, 2011, Pages 98-103

  Brown, Lynda M ^a   Hansen, Carl T ^b   Huberty, Andrea F ^c   Castonguay, T W ^c  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Corticosterone; Hypothalamic pituitary adrenal axis; Leptin; Neuropeptide Y; Obesity; Strain differences

Indexed keywords

CORTICOSTERONE; LEPTIN; NEUROPEPTIDE Y5 RECEPTOR;

ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CARCASS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DAHL SALT SENSITIVE RAT; FOOD INTAKE; HYPOTHALAMUS; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE;

ADIPOSE TISSUE; ADRENALECTOMY; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BODY COMPOSITION; BODY WEIGHT; CORTICOSTERONE; DISEASE MODELS, ANIMAL; EATING; HYPOTHALAMUS; LEPTIN; MALE; METABOLIC DISEASES; OBESITY; RATS; RATS, INBRED DAHL; RATS, INBRED SHR; RECEPTORS, NEUROPEPTIDE Y; RNA, MESSENGER; TIME FACTORS;

EID: 79952486756     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.12.020     Document Type: Article

References (48)

1. Levin B.E. Developmental gene×environment interactions affecting systems regulating energy homeostasis and obesity. Front Neuroendocrinol 2010, 31:270-283.
2. Kahle E.B., Butz K.G., Chua S.C., Kershaw E.E., Leibel R.L., Fenger T.W., et al. The rat corpulent (cp) mutation maps to the same interval on (Pgm1-Glut1) rat chromosome 5 as the fatty (fa) mutation. Obes Res 1997, 5(2):142-145.
3. Koletsky S. Obese spontaneously hypertensive rats-a model for the study of atherosclerosis. Exp Mol Pathol 1973, 19:53-60.
4. Zucker L., Zucker T. Fatty, a new mutation in the rat. J Hered 1961, 52:275-278.
5. Strack A.M., Sebastian R.J., Schwartz M.W., Dallman M.F. Glucocorticoids and insulin: reciprocal signals for energy balance. Am J Physiol 1995, 268:R142-R149.
6. Rohner-Jeanrenaud E., Jeanrenaud B. Central nervous system and body weight regulation. Ann Endocrinol (Paris) 1997, 58:137-142.
7. Guillaume-Gentil C., Rohner-Jeanrenaud F., Abramo F., Bestetti G.E., Rossi G.L., Jeanrenaud B. Abnormal regulation of the hypothalamo-pituitary-adrenal axis in the genetically obese fa/fa rat. Endocrinology 1990, 126(4):1873-1879.
8. Williams G., Shellard L., Lewis D.E., McKibbin P.E., McCarthy H.D., Koeslag D.G., et al. Hypothalamic neuropeptide Y disturbances in the obese (cp/cp) JCR:LA corpulent rat. Peptides 1992, 13:537-540.
9. Widdowson P.S. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor. Brain Res 1997, 758:17-25.
10. Hansen C.T. Development of the SHR/N and LA/N-corpulent (cp) congenic rat strains. New models of genetically obese rats for studies in diabetes, heart disease, and complications of obesity 1987, 7-13. NIH, Bethesda. C.T. Hansen, O.E. Michaelis (Eds.).
11. Michaelis O.E. Comparison of SHR/N- and LA/N-corpulent rat strains: metabolic characteristics. New models of genetically obese rats for studies in diabetes, heart disease, and complications of obesity 1987, 13-17. NIH, Bethesda. C. Hansen, O. Michaelis (Eds.).
12. Somanchi M., Ghosh P., Redman R.S., Lakshman M.R. Cholesterogenesis, lipogenesis, cholesterol degradation to bile acids, and histopathology of the liver in LA/N-cp obese rats. Hepatology 1997, 25:1451-1456.
13. Russell J.C., Kelly S.E., Diane A., Wang Y., Mangat R., Novak S., et al. Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome. Am J Physiol Gastrointest Liver Physiol 2010, 299:G507-G516.
14. Michaelis O.E., Carswell N., Hansen C.T., Canary J.J., Kimmel P.L. A new genetic model of noninsulin-dependent diabetes and hypertension:the spontaneous hypertensive/NIH corpulent rat. Frontiers in Diabetes Research 1988, 257-264. John Libbey & Company Ltd. E.E. Shafrir, A.E. Renold (Eds.).
15. Striffler J.S., Bhathena S.J., Michaelis O.E.T., Campbell J.D., Hansen C.T., Scalbert E., et al. Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension. Metabolism 1998, 47:1199-1204.
16. Okamoto K. Spontaneous hypertension in rats. Intl Rev Exp Pathol 1969, 7:227-270.
17. Hansen C., Potkay S., Watson W., Whitney R. NIH Rodents: 1980 Catalogue 1982, U.S. Depatment of Health and Human Services, Washington, DC.
18. Aleixandre de Artinano A., Miguel Castro M. Experimental rat models to study the metabolic syndrome. Br J Nutr 2009, 102:1246-1253.
19. Michaelis O.E.T., Velasquez M.T., Abraham A.A., Servetnick D.A., Scholfield D.J., Hansen C.T. Development and characteristics of a new strain of obese hyperinsulinemic and hyperlipidemic Dahl salt-sensitive rat. The Dahl salt-sensitive/NIH-corpulent rat. Am J Hypertens 1995, 8:467-473.
20. Rapp J.P., Dene H. Development and characteristics of inbred strains of Dahl salt- sensitive and salt-resistant rats. Hypertension 1985, 7:340-349.
21. Sustarsic D.L., McPartland R.P., Rapp J.P. Total and kallikrein arginine esterase activities in the urine of salt-hypertensive susceptible and resistant rats. Hypertension 1980, 2:813-820.
22. Rapp J.P. Dahl salt-susceptible and salt-resistant rats. A review. Hypertension 1982, 4:753-763.
23. Garrett M.R., Dene H., Rapp J.P. Time-course genetic analysis of albuminuria in Dahl salt-sensitive rats on low-salt diet. J Am Soc Nephrol 2003, 14:1175-1187.
24. Bray G.A., York D.A. The MONA LISA hypothesis in the time of leptin. Recent Prog Horm Res 1998, 53:95-117. discussion-8.
25. Anagnostis P., Athyros V.G., Tziomalos K., Karagiannis A., Mikhailidis D.P. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009, 94:2692-2701.
26. Walker B.R. Cortisol-cause and cure for metabolic syndrome?. Diabet Med 2006, 23:1281-1288.
27. Sen Y., Aygun D., Yilmaz E., Ayar A. Children and adolescents with obesity and the metabolic syndrome have high circulating cortisol levels. Neuro Endocrinol Lett 2008, 29:141-145.
28. DeOre K., Kamara K., Hansen C., Michaelis O., Castonguay T. Intracerebroventricular injections of dexamethasone do not promote insulin release in LA/N-cp adrenalectomized rats. Society for Neuroscience Abstract 1995.
29. Schemmel R., Mickelsen O., Gill J.L. Dietary obesity in rats: body weight and body fat accretion in seven strains of rats. J Nutr 1970, 100(9):1041-1048.
30. West D.B., Boozer C.N., Moody D.L., Atkinson R.L. Dietary obesity in nine inbred mouse strains. Am J Physiol 1992, 262(31):R1025-R1032.
31. West D.B., Waguespack J., McCollister S. Dietary obesity in the mouse: interaction of strain with diet composition. Am J Physiol 1995, 268:R658-R665.
32. Harris R.B., Mitchell T.D., Yan X., Simpson J.S., Redmann S.M. Metabolic responses to leptin in obese db/db mice are strain dependent. Am J Physiol Regul Integr Comp Physiol 2001, 281:R115-R132.
33. Madiehe A.M., Hebert S., Mitchell T.D., Harris R.B. Strain-dependent stimulation of growth in leptin-treated obese db/db mice. Endocrinology 2002, 143:3875-3883.
34. Faraday M.M. Rat sex and strain differences in responses to stress. Physiol Behav 2002, 75:507-522.
35. Faraday M.M., Blakeman K.H., Grunberg N.E. Strain and sex alter effects of stress and nicotine on feeding, body weight, and HPA axis hormones. Pharmacol Biochem Behav 2005, 80:577-589.
36. Levin B.E. Interaction of perinatal and pre-pubertal factors with genetic predisposition in the development of neural pathways involved in the regulation of energy homeostasis. Brain Res 2010, 1350:10-17.
37. White C.L., Ishii Y., Mendoza T., Upton N., Stasi L.P., Bray G.A., et al. Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity. Peptides 2005, 26:2331-2338.
38. Bray G.A. Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. J Nutr 1991, 121:1146-1162.
39. Schaffhauser A.O., Madiehe A.M., Braymer H.D., Bray G.A., York D.A. Effects of a high-fat diet and strain on hypothalamic gene expression in rats. Obes Res 2002, 10:1188-1196.
40. Johren O., Dendorfer A., Dominiak P., Raasch W. Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats. Brain Res 2007, 1184:160-167.
41. Fujita T. Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 2010, 55:813-818.
42. Iwai J., Knudsen K.D., Dahl L.K., Tassinari L. Effects of adrenalectomy on blood pressure in salt-fed, hypertension-prone rats. Failure of hypertension to develop in absence of evidence of adrenal cortical tissue. J Exp Med 1969, 129:663-678.
43. Campfield L., Smith F., Burn P. The OB protein (leptin) pathway-a link between adipose tissue mass and central neural networks. Horm Metab Res 1996, 28:619-632.
44. Campfield L.A. Central mechanisms responsible for the actions of OB protein (leptin) on food intake, metabolism and body energy storage. Front Horm Res 2000, 26:12-20.
45. Woods S.C., Seeley R.J., Porte D., Schwartz M.W. Signals that regulate food intake and energy homeostasis. Science 1998, 280:1378-1383.
46. Porte D., Seeley R.J., Woods S.C., Baskin D.G., Figlewicz D.P., Schwartz M.W. Obesity, diabetes and the central nervous system. Diabetologia 1998, 41:863-881.
47. Recant L., Voyles N.R., Timmers K.I., Bhathena S.J., Solomon D., Wilkins S., et al. Comparison of insulin secretory patterns in obese nondiabetic LA/N-cp and obese diabetic SHR/N-cp rats. Role of hyperglycemia. Diabetes 1989, 38:691-697.
48. Timmers K.I., Voyles N.R., Recant L. Genetically obese rats with (SHR/N-cp) and without diabetes (LA/N-cp) share abnormal islet responses to glucose. Metabolism 1992, 41:1125-1133.